Aimmune Therapeutics Inc. (AIMT) Rose 5.51% or 1.51 To Price $28.92 On Tuesday


Aimmune Therapeutics Inc. (AIMT) rose 5.51% or 1.51 to $28.92. It is nearly 556473 shares traded, which is 114.15% compare to the average total volume 487487. The market cap of AIMT is $1.68 billion. The year to date change is -21.18%. The 52 week price range is from $18.25 to $42.0. Price of AIMT have changed -7.77% during last week. It have changed -1.19% over last month, -11.69% over last 3 months, -22.83% over last 6 months and 27.37% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AIMT is 29.90. It is 3.39% above current price. The 200-day Moving Averages for AIMT is 32.48. It is 12.31% above current price. The 52-week High is 42.0. It is 45.23% from the current price. The 52-week Low is 18.25. It is -36.89% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AIMT is 10.0 on 2018-07-13. Short % to float is 10.29%. There are some statistics of AIMT. It is has market cap $1.68 billion. The share outstanding is 58.10 million. The average volume is 487487. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AIMT is -52.19%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AIMT is -48.57%.


Tags:

Share this post